SCHEMBL21754823

SCHEMBL21754823

CC1O[C@H](COC(=O)c2ccc(C(F)(F)F)cc2)[C@@H](OC(=O)c2ccc(C(F)(F)F)cc2)[C@@H]1F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN1 P18031 4/20 0.46
▸ F11 P03951 2/20 0.40
▸ PTPN2 P17706 1/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ ELANE P08246 1/20 0.39
▸ LGALS3 P17931 1/20 0.38
▸ LGALS4 P56470 1/20 0.38
▸ USP2 O75604 2/20 0.38
▸ L3MBTL1 Q9Y468 2/20 0.38
▸ TMPRSS2 O15393 1/20 0.38
▸ PDE5A O76074 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ HMGCR P04035 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ LCK P06239 1/20 0.38
▸ FYN P06241 1/20 0.38
▸ HSPD1 P10809 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CA6 P23280 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16756735 0.87 PTPN1 (0.47) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL21754792 0.87 HPGD (0.46) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL15481811 0.86 PTPN1 (0.50) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL15481874 0.86 PTPN1 (0.45) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL21754796 0.86 UPP1 (0.48) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL8389853 0.85 POLB (0.49) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL14208949 0.85 POLB (0.49) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL16926957 0.85 POLB (0.49) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL14931047 0.85 POLB (0.49) PTPN1F11PTPN2PTPN11ELANE
SCHEMBL25509971 0.85 POLB (0.49) PTPN1F11PTPN2PTPN11ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same FUJIFILM CORPORATION (JP) 2020-02-25 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10570112-B2 Synthetic intermediate of 1-(2-deoxy-2-fluoro-4-thio-β-D-arabinofuranosyl)cytosine, synthetic intermediate of thionucleoside, and method for producing the same TYMS, TYMP, RRM2B PTPN1 4173/4885F11 496/4885PTPN2 4338/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback